RBI's rupee dilemma

RBI’s rupee defence could hurt Indian economy

India’s low rupee volatility comes from aggressive RBI action, but structural reforms, not costly defence, will secure long-term stability. #RBI #rupee Read more »
Indian economy

Indian economy: Declining investment, household savings drag growth

Falling household savings, sluggish investment, and weak job growth threaten Indian economy’s long-term economic momentum. #Indianeconomy Read more »
Trump tariff

Export figures show India can weather Trump tariff shock

Electronics, gems, and pharma drove August’s export gains, proving that strategic diversification can counter Trump tariff barriers. Read more »
Concert tourism

Concert tourism could unlock new revenue for cities

Concert tourism is giving Indian cities fresh revenue streams, boosting municipal coffers and reshaping local public finance. #concert #tourism #economy Read more »
Private credit funds and NBFCs in India

NBFCs and private credit reshaping India’s finance ecosystem

Private credit funds and NBFCs are filling financing gaps, reshaping capital flows and easing pressure on banks in India’s credit market. Read more »
Uttar Pradesh’s exports-led growth in trouble

Uttar Pradesh bets on exports-led growth to realise $1 tn dream

Uttar Pradesh’s exports-led growth strategy faces bottlenecks in logistics, skilling, and global demand that could limit its economic impact. Read more »
Private investment

Weak private investment threatens India’s growth momentum

India’s 7.8% GDP growth figure masks a deeper malaise — corporate caution is holding back private investment. #GDP #capex Read more »
GDP growth

GDP growth: India tops global charts, but faces tariff risks

With impressive Q1 GDP growth figures, a stellar quarter puts India ahead of peers, but looming US tariffs threaten to dent exports and slow momentum. #Q1 #GDP Read more »
Trump tariffs on generic drugs

Trump Tariffs hit Indian pharma, patients in US may pay the price

Trump tariffs on Indian pharma will disrupt exports and drive up drug prices for American patients. Read more »